NUDT5 and breast carcinoma: however, multivariate analysis indicated that high NUDT5 expression was an independent prognostic factor for the OS of patients with breast cancer (hazard ratio [HR] 0.114; 95% confidence interval [CI] 0.021–0.612; P = 0.0113).